Kneat.com, Inc.

TSX:KSI.TO

Medical - Healthcare Information Services

Healthcare
$6.50 -0.16%

-$0.01 today

Market cap
$624.86M
Beta
1.37
P/E (TTM)
-73.0
EPS (TTM)
-$0.09
52W Low $3.23High $6.44

Volume 0.10M

Average 0.31M

KSI.TO Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Kneat.com, Inc.TSX: KSI.TO

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns negative

Q1 FY2026 accounts receivables was -CA$15.12M, compared with CA$5.48M a year earlier. Trailing-twelve-month accounts receivables was -CA$15.24M.

Context

  • Accounts receivables amounted to 8.5% of revenue in FY2025, down 4.2 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts receivables holds near -CA$15.12M or moves back toward the trailing-twelve-month quarterly average of -CA$3.81M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$15.12M+5829.0% QoQ
Last fiscal yearDec 2025
CA$5.36M+186.7% YoY
LTMMar 2026
-CA$15.24M-579.0% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-375.9%——
1 year+186.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

CAD · from the cash flow

Latest · FY2025
5.36M CAD
Year-over-year change
+186.7%

Accounts Receivables vs competitors

How KSI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -579.0% is the lowest of 7, against a peer median of -86.1%.
  • Accounts receivables amounts to 22.9% of revenue for KSI.TO, versus a peer median of 5.9%.
KSI.TO Competitors
Accounts Receivables for KSI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$34.55M CAD+870.4%—11.1%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$30.28M CAD+25.5%+0.1%5.9%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$15.24M CAD-579.0%—22.9%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$8.15M CAD-224.8%—2.6%
VHI.TOVitalhub Corp.LTM Mar 2026CA$6.99M CAD-355.7%—5.9%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.98M USD+159.2%—3.9%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$168K CAD-197.7%—6.1%
Peer median (excluding KSI.TO) —-86.1%+0.1%5.9%

Competitors are the stored peer set for KSI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(9.86M)(9.15M)(14.12M)(7.73M)(2.35M)
Depreciation & Amortization4.4M5.7M7.4M10.13M13.99M
Deferred Income Tax3.21M055.89K192.6K0
Stock-Based Compensation844.41K1.14M2.87M3.83M3.99M
Change in Working Capital3.39M5.06M2.87M1.11M2.25M
Accounts Receivables(1.18M)(1.61M)(2.3M)(6.18M)5.36M
Inventory(2.2M)(2.32M)000
Accounts Payables2.2M2.32M2.01M298.66K(286.39K)
Other Working Capital4.57M6.68M3.16M6.99M(2.83M)
Other Non-Cash Items321.19K240.5K(349.48K)2.26M(5.62M)
Operating Cash Flow2.31M2.99M(1.28M)9.79M12.26M
Capital Expenditures(10.04M)(12.82M)(17.16M)(19.88M)(279.64K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(9.4M)904.57K1.19M(17.36M)1.93M
Investing Cash Flow(10.04M)(11.91M)(15.97M)(17.52M)(20.1M)
Debt Repayment(1.23M)(999.76K)20.59M(3.22M)(6.6M)
Common Stock Issued22.13M615.85K(329.25K)55.63M1.42M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities302.13K615.85K(329.25K)(1.78M)(693.72K)
Financing Cash Flow21.2M(383.91K)20.27M50.62M(5.87M)
Effect of Forex Changes(560.54K)20.98K(47.11K)745.45K3.56M
Net Change in Cash12.9M(9.28M)2.97M43.64M(10.15M)
Free Cash Flow(7.74M)(9.82M)(18.39M)(10.09M)11.98M

Kneat.com, Inc.

TSX:KSI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.